These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26861734)

  • 21. MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma.
    Yamamoto K; Seike M; Takeuchi S; Soeno C; Miyanaga A; Noro R; Minegishi Y; Kubota K; Gemma A
    Oncol Rep; 2014 Dec; 32(6):2365-72. PubMed ID: 25231602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
    Kanteti R; Riehm JJ; Dhanasingh I; Lennon FE; Mirzapoiazova T; Mambetsariev B; Kindler HL; Salgia R
    Sci Rep; 2016 Sep; 6():32992. PubMed ID: 27623107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune Checkpoints Aberrations and Malignant Mesothelioma: Assessment of Prognostic Value and Evaluation of Therapeutic Potentials.
    Mohamed H; Eltobgy M; Abdel-Rahman O
    Anticancer Agents Med Chem; 2017; 17(9):1228-1233. PubMed ID: 28042777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manumycin A induces apoptosis in malignant pleural mesothelioma through regulation of Sp1 and activation of the mitochondria-related apoptotic pathway.
    Kim KH; Chae JI; Oh H; Cho JH; Lee RH; Yoon G; Cho SS; Cho YS; Lee MH; Liu K; Lee HJ; Shim JH
    Oncol Rep; 2016 Jul; 36(1):117-24. PubMed ID: 27176604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical investigation of folate receptor-targeted nanoparticles for photodynamic therapy of malignant pleural mesothelioma.
    Kato T; Jin CS; Lee D; Ujiie H; Fujino K; Hu HP; Wada H; Wu L; Chen J; Weersink RA; Kanno H; Hatanaka Y; Hatanaka KC; Kaga K; Matsui Y; Matsuno Y; De Perrot M; Wilson BC; Zheng G; Yasufuku K
    Int J Oncol; 2018 Nov; 53(5):2034-2046. PubMed ID: 30226590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion.
    Pulito C; Mori F; Sacconi A; Casadei L; Ferraiuolo M; Valerio MC; Santoro R; Goeman F; Maidecchi A; Mattoli L; Manetti C; Di Agostino S; Muti P; Blandino G; Strano S
    Oncotarget; 2015 Jul; 6(20):18134-50. PubMed ID: 26136339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma.
    Lam SK; Li YY; Zheng CY; Ho JC
    Int J Oncol; 2015 Jan; 46(1):113-22. PubMed ID: 25335113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts.
    Littlejohn JE; Cao X; Miller SD; Ozvaran MK; Jupiter D; Zhang L; Rodarte C; Smythe WR
    Int J Cancer; 2008 Jul; 123(1):202-8. PubMed ID: 18360826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A molecular targeting against nuclear factor-κB, as a chemotherapeutic approach for human malignant mesothelioma.
    Nishikawa S; Tanaka A; Matsuda A; Oida K; Jang H; Jung K; Amagai Y; Ahn G; Okamoto N; Ishizaka S; Matsuda H
    Cancer Med; 2014 Apr; 3(2):416-25. PubMed ID: 24510578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calpeptin Prevents Malignant Pleural Mesothelioma Cell Proliferation via the Angiopoietin1/Tie2 System.
    Tabata C; Tabata R; Nakano T
    Asian Pac J Cancer Prev; 2016; 17(7):3405-9. PubMed ID: 27509983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ponatinib is a potential therapeutic approach for malignant pleural mesothelioma.
    Yang YW; Marrufo A; Chase J; Woodard GA; Jablons DM; Lemjabbar-Alaoui H
    Exp Lung Res; 2021 Feb; 47(1):9-25. PubMed ID: 33107354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemosensitivity and cytokine sensitivity of malignant mesothelioma.
    Bowman RV; Manning LS; Davis MR; Robinson BW
    Cancer Chemother Pharmacol; 1991; 28(6):420-6. PubMed ID: 1934246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma.
    Li Q; Wang W; Machino Y; Yamada T; Kita K; Oshima M; Sekido Y; Tsuchiya M; Suzuki Y; Nan-Ya K; Iida S; Nakamura K; Iwakiri S; Itoi K; Yano S
    Cancer Sci; 2015 Jan; 106(1):102-7. PubMed ID: 25421609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin induces apoptosis and inhibits angiogenesis in murine malignant mesothelioma.
    Zhang C; Hao Y; Wu L; Dong X; Jiang N; Cong B; Liu J; Zhang W; Tang D; De Perrot M; Zhao X
    Int J Oncol; 2018 Dec; 53(6):2531-2541. PubMed ID: 30272283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antineoplastic activity of povidone-iodine on different mesothelioma cell lines: results of in vitro study.
    Fiorelli A; Pentimalli F; D'Urso V; Di Marzo D; Forte IM; Giordano A; Di Domenico M; Accardo M; Di Serio U; Santini M
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):993-1000. PubMed ID: 24394552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
    Kanteti R; Mirzapoiazova T; Riehm JJ; Dhanasingh I; Mambetsariev B; Wang J; Kulkarni P; Kaushik G; Seshacharyulu P; Ponnusamy MP; Kindler HL; Nasser MW; Batra SK; Salgia R
    Cancer Biol Ther; 2018 Apr; 19(4):316-327. PubMed ID: 29303405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer-Associated Fibroblasts Regulate Kinase Activity in Mesothelioma Cell Lines via Paracrine Signaling and Thereby Dictate Cell Faith and Behavior.
    Mathilakathu A; Wessolly M; Mairinger E; Uebner H; Kreidt D; Brcic L; Steinborn J; Greimelmaier K; Wohlschlaeger J; Schmid KW; Mairinger FD; Borchert S
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
    Jänne PA; Taffaro ML; Salgia R; Johnson BE
    Cancer Res; 2002 Sep; 62(18):5242-7. PubMed ID: 12234991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells.
    Jamal S; Cheriyan VT; Muthu M; Munie S; Levi E; Ashour AE; Pass HI; Wali A; Singh M; Rishi AK
    PLoS One; 2014; 9(3):e89146. PubMed ID: 24598827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.